drugset / Trial / NCT00396175

Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)

NCT00396175

Phase 3 Completed 355 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

A clinical study to collect additional data in order to characterize the reduction in PSA with finasteride 1 mg, and its reversibility in men with androgenetic alopecia between the ages of 40 to 60 years.

Timeline

Start
1998-03
Primary completion
2000-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Finasteride Small molecule 1 mg

Indications